HLA Tissue Typing Nyanhete T. E. et al. (2019). HLA class II-Restricted CD8+ T cells in HIV-1 Virus Controllers. Scientific Reports. DOI: 10.1038/s41598-019-46462-8 Link J et al. (2014). Human Leukocyte Antigen Genes and Interferon Beta Preparations Influence Risk of Developing Neutralizing Anti-Drug Antibodies in Multiple Sclerosis. PLOS One DOI: 10.1371/journal.pone.0090479 Mahlangu, J.N. et al. (2015). Changes in the amino acid sequence of the recombinant human factor VIIa analog, vatreptacog alfa, are associated with clinical immunogenicity. Journal of Thrombosis and Haemostasis. DOI: 10.1111/jth.13141 Donnelly, RP. et al. (2011). Interferon-lambda and therapy for chronic hepatitis C virus infection. Trends in Immunology. DOI: 10.1016/j.it.2011.07.002 Post navigationPrevious post: ProMap® T Cell Proliferation AssayNext post: Pro5® MHC Class I Pentamers